News

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
CompanyOverview|NYSE:HIMS] One of the more hotly debated stocks in the market, Hims & Hers Health (NYSE: HIMS), recently made ...
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, swelling that can be caused by cancer treatment.
But this is just the start. GLP-1 drugs (specifically Novo Nordisk’s Ozempic, Rybelsus and Wegovy and Eli Lilly’s Mounjaro ...
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
President Trump’s threatened tariffs could lead to higher out-of-pocket costs or insurance premiums, depending on whether ...
In his tariffs announcement on April 2, Trump also said the US no longer produces enough antibiotics, which like most generic ...
Trump is pushing for tariffs on pharmaceutical imports, citing concerns over the US’s dependency on foreign production, particularly in Europe and China. The ...
WeightWatchers faces bankruptcy with £1.25 billion ($1.6 billion) in debt, losing clients to drugs like Ozempic. Can the ...
WeightWatchers has plans to file for bankruptcy in the coming months, a source familiar with the matter said on Wednesday.
U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that ...